I

InMed Pharmaceuticals Inc. (INM)

NCM – Real Time Price. Currency in USD

1.43

-0.03 (-1.99%)

Market open: Aug 12, 2026, 12:20 PM EDT

1.41

-0.05 (-3.42%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

InMed Pharmaceuticals Inc. (INM)

NCM – Real Time Price. Currency in USD

1.43

-0.03 (-1.99%)

Market open: Aug 12, 2026, 12:20 PM EDT

1.41

-0.05 (-3.42%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

5M

4M

1M

Cost of goods sold

-4M

-3M

-1M

Gross Profit

1M

496K

1M

68K

Operating expenses (excl. COGS)

-9M

-10M

-14M

Operating Income

-8M

-14M

Non-operating income, total

-244K

466K

444K

-5M

Pretax income

-8M

-19M

Equity in earnings

0

Taxes

0

-7K

-13K

0

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-8M

-19M

Discontinued operations

0

Net income

-8M

-19M

Dilution adjustment

0

Preferred dividends

0

Search stocks

InMed Pharmaceuticals Inc. (INM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

InMed Pharmaceuticals Inc. (INM)

Income Statement (Annual)